Multiple Approaces to the Study of Steroidogenic Factor 1: Identification of a Novel Regulatory Element and Identification of Novel Target Genes

Total Page:16

File Type:pdf, Size:1020Kb

Multiple Approaces to the Study of Steroidogenic Factor 1: Identification of a Novel Regulatory Element and Identification of Novel Target Genes MULTIPLE APPROACES TO THE STUDY OF STEROIDOGENIC FACTOR 1: IDENTIFICATION OF A NOVEL REGULATORY ELEMENT AND IDENTIFICATION OF NOVEL TARGET GENES APPROVED BY SUPERVISORY COMMITTEE Keith L. Parker, M.D., Ph.D. Robert Hammer, Ph.D. Carole Mendelson, Ph.D. Andrew Zinn, M.D., Ph.D. To Joe “To love and be loved is to feel the sun from both sides” David Viscott MULTIPLE APPROACHES TO THE STUDY OF STEROIDOGENIC FACTOR 1: IDENTIFICATION OF A NOVEL REGULATORY ELEMENT AND IDENTIFICATION OF NOVEL TARGET GENES by NANCY RUTH STALLINGS DISSERTATION Presented to the Faculty of the Graduate School of Biomedical Sciences The University of Texas Southwestern Medical Center at Dallas In Partial Fulfillment of the Requirements For the Degree of DOCTOR OF PHILOSOPHY The University of Texas Southwestern Medical Center at Dallas Dallas, Texas April, 2005 Acknowledgments I would like to thank the many people that have been supportive of me. I have been very fortunate in meeting many great people throughout the years. My list of thanks starts even before enrolling in graduate school-it begins with the wonderful people that helped me adjust to my first “real job” after college. Judy, Diana, Diane, Karen, Carole and Mike---Thank you so much for all you were able to teach me. I was lucky to find a laboratory to do my dissertation research that also had many talented individuals and fantastic co-workers. Through the years I was able to learn a lot from them. Suria, Neil, Gregor, Liping, Marit, Nathan, Kimmie, Anne, Tomo, Tom, Gareth, and Yelena were great co-workers. It was a pleasure working with all of you. And finally my mentor-Keith Parker-who allowed me the freedom to explore my own ideas while giving me the guidance necessary to do the research. On a more personal level, I would also like to thank those outside the lab for their support and encouragement. Tom and Tara for their friendship throughout graduate school and members of the “Trivia Mofia” for endless hours of entertainment outside the lab, and my Mom and Dad for their encouragement—and unwavering belief that I can be successful in anything I try. Most of all, I would like to thank Joe, my husband of ten years. Day in and day out, Joe has been there for me and I am very lucky to have his support and encouragement. Copyright by Nancy Ruth Stallings, 2005 All Rights Reserved MULTIPLE APPROACHES TO THE STUDY OF STEROIDOGENIC FACTOR 1: IDENTIFICATION OF A NOVEL REGULATORY ELEMENT AND IDENTIFICATION OF NOVEL TARGET GENES Publication No. Nancy Ruth Stallings, Ph.D. The University of Texas Southwestern Medical Center at Dallas, 2005 Supervising Professor: Keith L. Parker, M.D., Ph.D. Steroidogenic Factor 1 (SF-1) is an essential component of the hypothalamic- pituitary-adrenal-gonadal axis. SF-1 knockout (KO) mice lack adrenals, gonads, the ventromedial hypothalamic nucleus (VMH), and pituitary gonadotropes. SF-1 is a transcription factor implicated in the regulation of many genes important in endocrine function. Research into the regulation of SF-1 expression, mostly focused on the proximal promoter, has been unable to fully explain the expression pattern of SF-1. I used DNase hypersensitivity mapping to search for novel regulatory regions of the SF-1 genomic region. One region between the 6th and 7th exons of SF-1 had tissue specific DNase I hypersensitivity. Analysis of this region revealed high conservation vi with the human genomic sequence and a smaller region that was also highly conserved in the chicken genomic sequence. Transient transfection assays and electrophoretic mobility shift assays have been employed to investigate this conserved element for enhancer activity. Numerous genes are target genes of SF-1, yet loss of known target genes fail to explain why the adrenals, gonads and VMH fail to develop in SF-1 KO mice. I used an SF-1/eGFP transgene as a reporter in both WT and KO E16.5 embryos. eGFP+ cells from the developing VMH of these mice were collected through the use of FACS. Several potential target genes of SF-1 have been identified and analysis of these genes is an ongoing project. vii PUBLICATIONS Zhao, L., Ikeda, I., Stallings, N.R., Tobet, S.A., Reuter, A.L., and K. L. Parker. CNS- specific Knockout of Steroidogenic Factor 1 Results in a Metabolic Syndrome and Increased Anxiety. In Preparation. Nef, S., Schaad, O., Cederroth, C., Pitetti, J., Stallings, N.R., Descombes, P. Parker, K.L., and Jean-Dominique Vassalli. Gene expression during sex determination reveals a robust female genetic program at the onset of early ovarian development. In Preparation. Stallings, N.R. Reuter, A.L., and K.L. Parker. Identification of a Conserved Intronic Element that Regulates the Cell-selective Expression of Steroidogenic Factor 1. In review. Segal, J.P., Stallings, N.R., Lee, C.E., Zhao, L., Socci, N.D., Viale, A., Harris, T.M., Soares, M., Childs, G., Elmquist, J., Parker, K.L., and J.M. Friedman. (2005). Use of Laser-Capture Microdissection for the Identification of Marker Genes for the Ventromedial Hypothalamic Nucleus. Journal of Neuroscience 25: 4181-4188. Davis, A.M., Seney, M.L., Stallings, N.R., Zhao, Z., Parker, K.L., and S.A. Tobet. (2004). Loss of steroidogenic factor 1 alters cellular topography in the mouse ventromedial nucleus of the hypothalamus. Journal of Neurobiology 60: 424-436. Cui, S., Ross, A., Stallings, N., Parker, K.L., Capel, B., and S E. Quaggin. (2004). Disrupted Gonadogenesis in Pod1 Mutant Mice. Development 131: 4095-105. Stallings, N.R., Hanley, N.A., Zhao, L., Majdic, G., Bakke, M., and K.L. Parker. (2002) Development of a Transgenic Green Fluorescent Protein Lineage Marker for Steroidogenic Factor 1. Molecular Endocrinology 16: 2360-2370. Shet, M.S., McPhaul, M., Fisher, C.W., Stallings, N.R., and R.W. Estabrook. (1997). Metabolism of the antiandrogenic drug (Flutamide) by human CYP1A2. Drug Metabolism & Disposition 25: 1298-303. viii TABLE OF CONTENTS PUBLICATIONS............................................................................................................................................ VIII TABLE OF CONTENTS.................................................................................................................................. IX FIGURE AND TABLE LIST ...........................................................................................................................XII ABBREVIATIONS......................................................................................................................................... XIII CHAPTER 1 INTRODUCTION TO STEROIDOGENIC FACTOR 1 .....................................................1 1.1 IDENTIFICATION OF STEROIDOGENIC FACTOR 1.........................................................................1 A Common Element in the Promoter of Several Cytochrome P450 Genes...................................................1 Genomic organization of the Nr5a1 locus ....................................................................................................1 1.2 EXPRESSION OF SF-1..............................................................................................................4 SF-1 is expressed in a cell-and tissue-selective manner ...............................................................................4 1.3 CHARACTERIZATION OF SF-1 KO MICE ....................................................................................5 Global SF-1 knockout mice fail to develop gonads, adrenals, and the ventromedial hypothalamic nucleus5 Tissue specific KO of SF-1............................................................................................................................8 1.4 TRANSCRIPTIONAL REGULATION OF SF-1 ...............................................................................10 Global Regulation of SF-1 Expression .......................................................................................................10 Tissue and Cell Specific Regulation of SF-1 Expression ............................................................................12 1.5 SF-1 TARGET GENES.............................................................................................................13 SF-1 binding sites .......................................................................................................................................13 Target Genes of SF-1 can be in steroidogenic and non-steroidogenic cells...............................................13 1.6 SF-1 PROTEIN ......................................................................................................................15 SF-1 has the protein structure of a typical nuclear hormone receptor.......................................................15 Phosphorylation and acetylation of SF-1 regulate transcriptional activity................................................16 Crystal Structures of SF-1 reveal a potential ligand for SF-1 ....................................................................17 Activation of transcription by SF-1 is modified by co-activators and co-repressors..................................17 Co-Activators..............................................................................................................................................19 Co-repressors..............................................................................................................................................23 1.7 LIVER RECEPTOR HOMOLOG 1 ................................................................................................26 1.8 HUMAN MUTATIONS OF SF-1
Recommended publications
  • Edinburgh Research Explorer
    Edinburgh Research Explorer International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list Citation for published version: Davenport, AP, Alexander, SPH, Sharman, JL, Pawson, AJ, Benson, HE, Monaghan, AE, Liew, WC, Mpamhanga, CP, Bonner, TI, Neubig, RR, Pin, JP, Spedding, M & Harmar, AJ 2013, 'International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands', Pharmacological reviews, vol. 65, no. 3, pp. 967-86. https://doi.org/10.1124/pr.112.007179 Digital Object Identifier (DOI): 10.1124/pr.112.007179 Link: Link to publication record in Edinburgh Research Explorer Document Version: Publisher's PDF, also known as Version of record Published In: Pharmacological reviews Publisher Rights Statement: U.S. Government work not protected by U.S. copyright General rights Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s) and / or other copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated with these rights. Take down policy The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer content complies with UK legislation. If you believe that the public display of this file breaches copyright please contact [email protected] providing details, and we will remove access to the work immediately and investigate your claim. Download date: 02. Oct. 2021 1521-0081/65/3/967–986$25.00 http://dx.doi.org/10.1124/pr.112.007179 PHARMACOLOGICAL REVIEWS Pharmacol Rev 65:967–986, July 2013 U.S.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • 3398 Orphan Nuclear Receptor Function in the Ovary Huajun Zhao1, Zili
    [Frontiers in Bioscience 12, 3398-3405, May 1, 2007] Orphan nuclear receptor function in the ovary Huajun Zhao1, Zili Li1, Austin J. Cooney2, Zi-Jian Lan1 1Birth Defects Center, Department of Molecular, Cellular and Craniofacial Biology, University of Louisville Health Sciences Center, Louisville, KY 40202 2Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030 TABLE OF CONTENTS 1. Abstract 2. Introduction 3. Germ Cell Nuclear Factor 4. Steroidogenic Factor-1 5. Liver Receptor Homolog-1 6. Perspective 7. Acknowledgement 8. References 1. ABSTRACT 2. INTRODUCTION Orphan nuclear receptors such as germ cell In the mammalian ovary, follicles are the nuclear factor (GCNF), steroidogenic factor 1 (SF-1) and principal functional units which provide the support system liver receptor homolog-1 (LRH-1), are emerging as necessary for production of female germ cells (mature important ovarian factors in regulating female oocytes) during postnatal life (1). The process of follicular reproduction. Within the ovary, GCNF (NR6A1) development after birth is termed folliculogenesis and the expression is restricted to the oocyte, while SF-1 (NR5A1) production of fertilizable eggs is referred to as oogenesis. is expressed only in the somatic cells, such as granulosa, During reproductive life, folliculogenesis and oogenesis are thecal and luteal cells, and interstitial cells. LRH-1 highly coordinated to ensure the production of fertilizable (NR5A2), an orphan receptor closely related to SF-1, is eggs. These processes require intercellular communication expressed only in the granulosa cells of the follicles and between many cell types such as oocytes, granulosa and luteal cells within the ovary. Recent studies using thecal cells within the ovary (2, 3).
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2003/0082511 A1 Brown Et Al
    US 20030082511A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2003/0082511 A1 Brown et al. (43) Pub. Date: May 1, 2003 (54) IDENTIFICATION OF MODULATORY Publication Classification MOLECULES USING INDUCIBLE PROMOTERS (51) Int. Cl." ............................... C12O 1/00; C12O 1/68 (52) U.S. Cl. ..................................................... 435/4; 435/6 (76) Inventors: Steven J. Brown, San Diego, CA (US); Damien J. Dunnington, San Diego, CA (US); Imran Clark, San Diego, CA (57) ABSTRACT (US) Correspondence Address: Methods for identifying an ion channel modulator, a target David B. Waller & Associates membrane receptor modulator molecule, and other modula 5677 Oberlin Drive tory molecules are disclosed, as well as cells and vectors for Suit 214 use in those methods. A polynucleotide encoding target is San Diego, CA 92121 (US) provided in a cell under control of an inducible promoter, and candidate modulatory molecules are contacted with the (21) Appl. No.: 09/965,201 cell after induction of the promoter to ascertain whether a change in a measurable physiological parameter occurs as a (22) Filed: Sep. 25, 2001 result of the candidate modulatory molecule. Patent Application Publication May 1, 2003 Sheet 1 of 8 US 2003/0082511 A1 KCNC1 cDNA F.G. 1 Patent Application Publication May 1, 2003 Sheet 2 of 8 US 2003/0082511 A1 49 - -9 G C EH H EH N t R M h so as se W M M MP N FIG.2 Patent Application Publication May 1, 2003 Sheet 3 of 8 US 2003/0082511 A1 FG. 3 Patent Application Publication May 1, 2003 Sheet 4 of 8 US 2003/0082511 A1 KCNC1 ITREXCHO KC 150 mM KC 2000000 so 100 mM induced Uninduced Steady state O 100 200 300 400 500 600 700 Time (seconds) FIG.
    [Show full text]
  • Independent Regulation of Vertebral Number and Vertebral Identity by Microrna-196 Paralogs
    Independent regulation of vertebral number and vertebral identity by microRNA-196 paralogs Siew Fen Lisa Wonga,1, Vikram Agarwalb,c,d,e,1, Jennifer H. Mansfieldf,g, Nicolas Denansh, Matthew G. Schwartzf, Haydn M. Prosseri, Olivier Pourquiéf,j, David P. Bartelb,c,d, Clifford J. Tabinf,2, and Edwina McGlinna,f,2 aEMBL Australia, Australian Regenerative Medicine Institute, Monash University, Clayton, VIC 3800, Australia; bHoward Hughes Medical Institute, Cambridge, MA 02142; cWhitehead Institute for Biomedical Research, Cambridge, MA 02142; dDepartment of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139; eComputational and Systems Biology Program, Massachusetts Institute of Technology, Cambridge, MA 02139; fDepartment of Genetics, Harvard Medical School, Boston, MA 02115; gDepartment of Biological Sciences, Barnard College, New York, NY 10027; hDepartment of Developmental Biology and Genetics, Stanford School of Medicine, Stanford, CA 94305; iThe Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, United Kingdom; and jDepartment of Pathology, Brigham and Women’s Hospital, Boston, MA 02115 Contributed by Clifford J. Tabin, July 16, 2015 (sent for review March 24, 2015; reviewed by Jacqueline Deschamps and Joshua T. Mendell) The Hox genes play a central role in patterning the embryonic anterior- of which is a critical factor in establishing species-specific vertebral to-posterior axis. An important function of Hox activity in verte- number (8). brates is the specification of different vertebral morphologies, with Within vertebral precursors, specific combinations of Hox an additional role in axis elongation emerging. The miR-196 family transcription factors impart positional information that governs of microRNAs (miRNAs) are predicted to extensively target Hox 3′ vertebral identity (9).
    [Show full text]
  • Strategies to Study Sex-Determining Genes in the Mouse
    Strategies to study sex-determining genes in the mouse Amy E. Johnson A thesis submitted to the University of London in fulfilment of the requirements for the degree of Doctor of Philosophy. May 2002 Division of Developmental Genetics, National Institute For Medical Research, The Ridgeway, Mill Hill, London, NW7 lAY. ProQuest Number: U643301 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a complete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. uest. ProQuest U643301 Published by ProQuest LLC(2015). Copyright of the Dissertation is held by the Author. All rights reserved. This work is protected against unauthorized copying under Title 17, United States Code. Microform Edition © ProQuest LLC. ProQuest LLC 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, Ml 48106-1346 This thesis is dedicated to my immediate family, Janice, Clive, Molly, Matthew, Ben, Emma and my fiancé Geoff Table Of Contents ACKNOWLEDGEMENTS ............................................ / ABSTRACT ....................................................................................................................IV 1 CHAPTER 1- GENERAL INTRODUCTION....................................................... 1 lA SEX DETERMINATION......................................................................................1 1.1.1 Drosophila and C-ele^ans .................................................................................1
    [Show full text]
  • Testing a Mesendoderm Protocol in Smad5 and Smad1/5 Depleted Embryonic Stem Cells for Primordial Germ Cell Induction
    UNIVERSIDADE DE LISBOA FACULDADE DE CIÊNCIAS DEPARTAMENTO DE BIOLOGIA ANIMAL Testing a mesendoderm protocol in Smad5 and Smad1/5 depleted embryonic stem cells for primordial germ cell induction Mestrado em Biologia Evolutiva e do Desenvolvimento Sara Mariana Eugénio Ferraz Mendes Dissertação orientada por: Professora Dra. Susana Marina Chuva de Sousa Lopes e Professora Dra. Maria Gabriela Rodrigues 2015 Contents i. Acknowledgements ................................................................................................................................ I ii. Abbreviations .................................................................................................................................... II iii. Abstract ............................................................................................................................................ III iv. Resumo ............................................................................................................................................ IV I. Introduction .............................................................................................................................. 1 1. Embryonic Stem Cells in mouse ............................................................................................ 2 2. BMP signalling: BMP4 and Smads 1/5 .................................................................................. 3 3. Primordial germ cells (PGCS)................................................................................................
    [Show full text]
  • Les Hormones Thyroïdiennes, Leurs Récepteurs Et L'évolution De La
    Les hormones thyroïdiennes, leurs récepteurs et l’évolution de la métamorphose chez les Chordés. Mathilde Paris To cite this version: Mathilde Paris. Les hormones thyroïdiennes, leurs récepteurs et l’évolution de la métamorphose chez les Chordés.. Biochimie [q-bio.BM]. Ecole normale supérieure de lyon - ENS LYON, 2008. Français. tel-00366311 HAL Id: tel-00366311 https://tel.archives-ouvertes.fr/tel-00366311 Submitted on 6 Mar 2009 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. THÈSE Présentée devant L’ECOLE NORMALE SUPÉRIEURE DE LYON pour l’obtention du DIPLÔME DE DOCTORAT soutenue le 18 décembre 2008 par MATHILDE PARIS THYROIDHORMONES,THEIRRECEPTORS AND THE EVOLUTION OF METAMORPHOSIS IN CHORDATES Jury: Vincent LAUDET Directeur de thèse Béatrice DESVERGNE Rapportrice Detlev ARENDT Rapporteur Philippe JANVIER Examinateur Nicholas HOLLAND Examinateur Frédéric FLAMANT Examinateur Hector ESCRIVA Membre invité THYROIDHORMONES,THEIRRECEPTORS ANDTHEEVOLUTIONOFMETAMORPHOSIS INCHORDATES mathilde paris Doctorate of Life Science 18 December 2008 ABSTRACT In an attempt to understand how the regulation of development evolves, particular attention has been put on transcription factors, which regulate gene expression during development. Among transcription factors, nuclear hormone receptors (NRs) have a peculiar status linked to their ligand-dependent activity.
    [Show full text]
  • <Abstract Centered> an ABSTRACT of the THESIS OF
    AN ABSTRACT OF THE DISSERTATION OF Michael Austin Garland for the degree of Doctor of Philosophy in Toxicology presented on June 14, 2019. Title: Transcriptomic Approaches for Discovering Regenerative and Developmental Regulatory Networks in Zebrafish Abstract approved: _____________________________________________________________________ Robert L. Tanguay Zebrafish are capable of fully regenerating organs and tissue such as their caudal fin, which is similar to a human regrowing an arm or a leg. In contrast, most mammals including humans have a greatly reduced capacity for wound healing. The ability of zebrafish to undergo this regenerative process, called epimorphic regeneration, hinges on the capacity to form a blastema at the wound site. The blastema quickly recapitulates the developmental processes involved in complex tissue formation to restore lost or damaged tissue. One key mechanism for inducing blastema formation is global repression of genes involved in tissue differentiation and maintenance. Induction of repressive factors, such as microRNAs (miRNAs), are involved in reprogramming cells during epimorphic regeneration. The upstream mechanism by which zebrafish undergo epimorphic regeneration remains elusive. Furthermore, while focus is shifting toward regulatory RNAs such as miRNAs, the full complement of their repressive activities is unknown. We took a transcriptomics approach to investigating epimorphic regeneration and fin development. Parallel sequencing of total RNA and small RNA samples was performed on regenerating fin tissue at 1 day post-amputation (dpa). Most miRNAs had increased expression, consistent with global repression of genes involved in cell specialization during de-differentiation. We identified predicted interactions between miRNAs and genes involved in transcriptional regulation, chromatin modification, and developmental signaling. miR-146a and miR-146b are anti- inflammatory miRNAs that were predicted to target eya4, which is involved in chromatin remodeling and innate immunity.
    [Show full text]
  • Oct-4: More Than a Pluripotent Marker? Ketkar Alhad Ashok, M.Sc., KVR Reddy, Ph.D.*
    Review Article Oct-4: More than a Pluripotent Marker? Ketkar Alhad Ashok, M.Sc., KVR Reddy, Ph.D.* Molecular Immunology Division Department, National Institute for Research in Reproductive Health, Parel, Mumbai, India * Corresponding Address: Molecular Immunology Division Departmetn, National Institute for Research in Reproductive Health, J. M. Street, Parel, Mumbai-400012, India Email: [email protected] Abstract Received: 23/Sep/2008, Accepted: 23/Nov/2008 Oct-4/ Pou5f1/ Oct-3, a POU domain family protein acts as a crucial transcription factor dur- ing embryonic development. It helps in maintenance of self renewal as well as pluripotential state of embryonic stem (ES) cells. Its expression starts right from 2 cell stage especially prior to 8 cell stage till the blastocyst stage where it is strongly expressed in inner cell mass (ICM). Thereafter, it is located predominantly in primordial germ cells (PGCs) till the birth. It targets particularly those genes which bear an octameric motif ATGCAAAT in promoter or enhancer region. Most of the target genes of Oct-4 are expressed in undifferentiated ES cells and knockdown of Oct-4 results in ES cell differentiation as a result of down regulation of targets of Oct-4 which are expressed in ES cells. Since, Oct-4 is crucial for embryo survival its expression needs tight regulation. Oct-4 is carefully regulated epigenetically as well as by several other factors. DNA methylation and histone modification play an important role in expression of Oct-4 while proximal promoter, enhancer and distal enhancer are the crucial regulatory elements present on Oct-4 upstream region. There is increasing evidence that Oct-4 is expressed in adult stem cells and these stem cells can get converted to cancer stem cells.
    [Show full text]
  • Br J Pharmacol
    Supplementary Information Supplementary Table 1. List of polypeptide cell surface receptor and their cognate ligand genes. Supplementary Table 2. List of coding SNPs with high FST ( > 0.5) in human GPCR and their cognate ligand genes. Supplementary Table 3. List of coding SNPs with high FST ( > 0.5) in human nonGPCR receptor and ligand genes. Supplementary Table 4. List of genotyped SNPs from 44246961 to 44542055 on chromosome 17. The HapMap II dataset was analyzed using HaploView. The 101 SNPs included in LD plots of Supplementary Fig. 3 (A-C) are highlighted by a grey background. The 37 SNPs used in the haplotype analysis of Fig. 2C are indicated by red letters. SNPs that are linked with rs2291725 are indicated by bold red letters. Supplementary Table 5. Allele frequency of rs2291725 in the HGDP-CEPH populations. Frequencies of GIP103T and GIP103C alleles in each of the 52 populations from the seven geographical regions and the number of chromosomes analyzed for each population. 1 Supplementary Table 6. EC50 values for GIP receptor activation at four different time points after incubation with pooled human serum or pooled complement-preserved human serum (N=4). Supplementary Table 7. EC50 values for GIP receptor activation at three different time points after incubation with a recombinant DPP IV enzyme (N=4). Supplementary Fig. 1. Cumulative distribution function (CDF) plots for the FST of coding SNPs in human GPCRs and their cognate ligand genes (blue) and all other human genes (magenta). The FST was computed between three HapMap II populations (CEU, YRI, and ASN), and coding SNPs have been split into synonymous and nonsynonymous groups.
    [Show full text]
  • Adenylyl Cyclase 2 Selectively Regulates IL-6 Expression in Human Bronchial Smooth Muscle Cells Amy Sue Bogard University of Tennessee Health Science Center
    University of Tennessee Health Science Center UTHSC Digital Commons Theses and Dissertations (ETD) College of Graduate Health Sciences 12-2013 Adenylyl Cyclase 2 Selectively Regulates IL-6 Expression in Human Bronchial Smooth Muscle Cells Amy Sue Bogard University of Tennessee Health Science Center Follow this and additional works at: https://dc.uthsc.edu/dissertations Part of the Medical Cell Biology Commons, and the Medical Molecular Biology Commons Recommended Citation Bogard, Amy Sue , "Adenylyl Cyclase 2 Selectively Regulates IL-6 Expression in Human Bronchial Smooth Muscle Cells" (2013). Theses and Dissertations (ETD). Paper 330. http://dx.doi.org/10.21007/etd.cghs.2013.0029. This Dissertation is brought to you for free and open access by the College of Graduate Health Sciences at UTHSC Digital Commons. It has been accepted for inclusion in Theses and Dissertations (ETD) by an authorized administrator of UTHSC Digital Commons. For more information, please contact [email protected]. Adenylyl Cyclase 2 Selectively Regulates IL-6 Expression in Human Bronchial Smooth Muscle Cells Document Type Dissertation Degree Name Doctor of Philosophy (PhD) Program Biomedical Sciences Track Molecular Therapeutics and Cell Signaling Research Advisor Rennolds Ostrom, Ph.D. Committee Elizabeth Fitzpatrick, Ph.D. Edwards Park, Ph.D. Steven Tavalin, Ph.D. Christopher Waters, Ph.D. DOI 10.21007/etd.cghs.2013.0029 Comments Six month embargo expired June 2014 This dissertation is available at UTHSC Digital Commons: https://dc.uthsc.edu/dissertations/330 Adenylyl Cyclase 2 Selectively Regulates IL-6 Expression in Human Bronchial Smooth Muscle Cells A Dissertation Presented for The Graduate Studies Council The University of Tennessee Health Science Center In Partial Fulfillment Of the Requirements for the Degree Doctor of Philosophy From The University of Tennessee By Amy Sue Bogard December 2013 Copyright © 2013 by Amy Sue Bogard.
    [Show full text]